Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Forma Therapeutics patents HDAC6 inhibitors

March 5, 2020

Epigenetic therapy disrupts premetastatic microenvironment

March 5, 2020

Medshine Discovery discloses new PI3K inhibitors

March 4, 2020

Modern Biosciences patents anti-cancer compounds

March 4, 2020

Bristol-Myers Squibb describes new protein-arginine deiminase type-4 inhibitors

March 4, 2020

New mouse model of gastric premalignancy integrating TP53 deletion with environmental exposures

March 4, 2020

How cancer cells hibernate

March 4, 2020

Phase III BOSTON study of Xpovio in multiple myeloma meets primary endpoint

March 3, 2020

XIST is a novel therapeutic target for treating laryngeal squamous cell carcinoma

March 3, 2020

Merck & Co. discloses new IDO-1 inhibitors

March 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...